Published in Int J Pharm on June 13, 2008
Basics and recent advances in peptide and protein drug delivery. Ther Deliv (2013) 0.98
Risk assessment of excess drug and sunscreen absorption via skin with ablative fractional laser resurfacing : optimization of the applied dose for postoperative care. Lasers Med Sci (2013) 0.78
Synergistic Effect and Mechanism of Cineole and Terpineol on In-vitro Transdermal Delivery of Huperzine A from Microemulsions. Iran J Pharm Res (2013) 0.75
Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel. Int J Nanomedicine (2016) 0.75
Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A (1987) 8.53
Penetration enhancers. Adv Drug Deliv Rev (2004) 3.55
An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry (1996) 3.16
Membrane thinning caused by magainin 2. Biochemistry (1995) 3.03
Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta (1998) 2.71
PREPARATION OF ISOLATED SHEETS OF HUMAN STRATUM CORNEUM. Arch Dermatol (1963) 2.49
Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med (2000) 2.40
Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry (1994) 1.94
Transdermal protein delivery by a coadministered peptide identified via phage display. Nat Biotechnol (2006) 1.91
Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci (1998) 1.84
Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun (1997) 1.75
Determination of glomerular size-selectivity in the normal rat with Ficoll. J Am Soc Nephrol (1992) 1.42
pH as a trigger of peptide beta-sheet self-assembly and reversible switching between nematic and isotropic phases. J Am Chem Soc (2003) 1.32
Spatially confined and temporally resolved refractive index and scattering evaluation in human skin performed with optical coherence tomography. J Biomed Opt (2000) 1.25
Modulation of magainin 2-lipid bilayer interactions by peptide charge. Biochemistry (1997) 1.24
Morphometry of human epidermis in vivo by real-time confocal microscopy. Arch Dermatol Res (1993) 1.03
Transdermal delivery enhanced by magainin pore-forming peptide. J Control Release (2007) 1.02
Characterization of the iontophoretic permselectivity properties of human and pig skin. J Control Release (2001) 1.02
Enhancement of transdermal drug delivery: chemical and physical approaches. Crit Rev Ther Drug Carrier Syst (2000) 0.99
Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr Drug Deliv (2004) 0.99
Effect of salt on the interactions of antimicrobial peptides with zwitterionic lipid bilayers. Biochim Biophys Acta (2006) 0.91
pH-dependent pore formation properties of pardaxin analogues. J Biol Chem (1991) 0.91
Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm (2005) 0.90
Effect of pH on skin permeation enhancement of acidic drugs by l-menthol-ethanol system. Int J Pharm (2001) 0.80
Studies on the effect of pH on the lipoidal route of penetration across stratum corneum. J Control Release (2001) 0.79
Design, synthesis and structure of an amphipathic peptide with pH-inducible haemolytic activity. Protein Eng (1992) 0.79
Optimization of transdermal delivery using magainin pore-forming peptide. J Phys Chem Solids (2008) 0.78
Effects of pH-induced variations of the charge of the transmembrane alpha-helical peptide Ac-K2(LA)12K2-amide on the organization and dynamics of the host dimyristoylphosphatidylcholine bilayer membrane. Biochim Biophys Acta (2005) 0.77
Dissolving polymer microneedle patches for influenza vaccination. Nat Med (2010) 3.24
Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci U S A (2003) 2.82
Coated microneedles for transdermal delivery. J Control Release (2006) 2.66
Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev (2012) 2.65
Effect of microneedle design on pain in human volunteers. Clin J Pain (2008) 2.48
Dissolving microneedles for transdermal drug delivery. Biomaterials (2008) 2.47
Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release (2005) 2.19
Transdermal delivery of insulin using microneedles in vivo. Pharm Res (2004) 2.07
Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol (2006) 2.02
Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech (2004) 1.91
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci U S A (2009) 1.82
Micro-scale devices for transdermal drug delivery. Int J Pharm (2008) 1.81
Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One (2009) 1.78
Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci U S A (2008) 1.77
Polymer microneedles for controlled-release drug delivery. Pharm Res (2006) 1.72
Coating formulations for microneedles. Pharm Res (2007) 1.63
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release (2009) 1.62
Precise microinjection into skin using hollow microneedles. J Invest Dermatol (2006) 1.51
Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mater (2008) 1.49
Mechanism of fluid infusion during microneedle insertion and retraction. J Control Release (2006) 1.46
Measurement and correlation of acoustic cavitation with cellular bioeffects. Ultrasound Med Biol (2006) 1.43
Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One (2009) 1.42
In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm (2008) 1.40
Physical parameters influencing optimization of ultrasound-mediated DNA transfection. Ultrasound Med Biol (2004) 1.37
Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis (2010) 1.36
Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses. Nat Nanotechnol (2010) 1.36
Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng (2005) 1.35
Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery. IEEE Trans Biomed Eng (2007) 1.30
Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol (2010) 1.22
Kinetics of skin resealing after insertion of microneedles in human subjects. J Control Release (2011) 1.21
Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res (2010) 1.20
Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol Ther (2009) 1.19
Bioeffects caused by changes in acoustic cavitation bubble density and cell concentration: a unified explanation based on cell-to-bubble ratio and blast radius. Ultrasound Med Biol (2003) 1.19
Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci U S A (2009) 1.18
Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res (2007) 1.17
Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. Diabetes Technol Ther (2005) 1.17
Dissolving microneedle patch for transdermal delivery of human growth hormone. Small (2011) 1.17
Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine (2009) 1.16
Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection. Sci Rep (2012) 1.14
Microinfusion using hollow microneedles. Pharm Res (2006) 1.13
Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs. J Pharm Sci (2010) 1.13
Quantification of optison bubble size and lifetime during sonication dominant role of secondary cavitation bubbles causing acoustic bioeffects. J Acoust Soc Am (2004) 1.12
The effect of heat on skin permeability. Int J Pharm (2008) 1.11
An electrically active microneedle array for electroporation. Biomed Microdevices (2010) 1.10
Formation and closure of microchannels in skin following microporation. Pharm Res (2010) 1.10
Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs. J Pharm Sci (2010) 1.09
A microneedle roller for transdermal drug delivery. Eur J Pharm Biopharm (2010) 1.08
Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci (2012) 1.07
Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res (2008) 1.07
Does needle size matter? J Diabetes Sci Technol (2007) 1.05
Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release (2010) 1.05
Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Diabetes Technol Ther (2011) 1.05
Separable arrowhead microneedles. J Control Release (2010) 1.05
Shear-induced intracellular loading of cells with molecules by controlled microfluidics. Biotechnol Bioeng (2008) 1.04
Coated microneedles for drug delivery to the eye. Invest Ophthalmol Vis Sci (2007) 1.04
Stability of influenza vaccine coated onto microneedles. Biomaterials (2012) 1.04
Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin. Biomacromolecules (2010) 1.03
Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res (2010) 1.03
Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res (2010) 1.03
Measles vaccination using a microneedle patch. Vaccine (2012) 1.03
Future directions for therapeutic ultrasound. Ultrasound Med Biol (2007) 1.03
Local response to microneedle-based influenza immunization in the skin. MBio (2012) 1.03
Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats. Pharm Res (2007) 1.02
Transdermal delivery enhanced by magainin pore-forming peptide. J Control Release (2007) 1.02
Equilibrium loading of cells with macromolecules by ultrasound: effects of molecular size and acoustic energy. J Pharm Sci (2002) 1.02
Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol (2010) 1.01
Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro. Pharm Res (2008) 1.01
Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination. J Infect Dis (2011) 1.01
Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine (2012) 1.00
Tissue electroporation: quantification and analysis of heterogeneous transport in multicellular environments. Biophys J (2004) 0.99
Formulation of microneedles coated with influenza virus-like particle vaccine. AAPS PharmSciTech (2010) 0.98
Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J Pharm Pharmacol (2008) 0.98
Bacillus Calmette-Guérin vaccination using a microneedle patch. Vaccine (2011) 0.98
Ultrasonically targeted delivery into endothelial and smooth muscle cells in ex vivo arteries. J Control Release (2007) 0.98
Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine. PLoS One (2012) 0.96
Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity. Clin Vaccine Immunol (2011) 0.96
Modeling transmembrane transport through cell membrane wounds created by acoustic cavitation. Biophys J (2008) 0.96
Microchannels created by sugar and metal microneedles: characterization by microscopy, macromolecular flux and other techniques. J Pharm Sci (2010) 0.96
Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Exp Eye Res (2004) 0.95
Dermal, subdermal, and systemic concentrations of granisetron by iontophoretic delivery. Pharm Res (2005) 0.95
Changes in cell morphology due to plasma membrane wounding by acoustic cavitation. Ultrasound Med Biol (2010) 0.95
Enabling skin vaccination using new delivery technologies. Drug Deliv Transl Res (2011) 0.94
Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets. Int J Pharm (2008) 0.93
Synergistic enhancement of skin permeability by N-lauroylsarcosine and ethanol. Int J Pharm (2007) 0.93
Inhibition of crystallization in drug-in-adhesive-type transdermal patches. Int J Pharm (2010) 0.92
Pocketed Microneedles for Drug Delivery to the Skin. J Phys Chem Solids (2008) 0.92
Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye. Adv Healthc Mater (2014) 0.92
Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res (2012) 0.91
Rapid local anesthesia in humans using minimally invasive microneedles. Clin J Pain (2012) 0.91
Recovery of skin barrier properties after sonication in human subjects. Ultrasound Med Biol (2009) 0.91
Direct quantitation of active ingredients in solid artesunate antimalarials by noncovalent complex forming reactive desorption electrospray ionization mass spectrometry. J Am Soc Mass Spectrom (2007) 0.91
Characterization of microchannels created by metal microneedles: formation and closure. AAPS J (2011) 0.91
Model of transient drug diffusion across cornea. J Control Release (2004) 0.90
Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. J Control Release (2012) 0.90
Selective removal of stratum corneum by microdermabrasion to increase skin permeability. Eur J Pharm Sci (2009) 0.90
Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine (2010) 0.89
Influence of the cell wall on intracellular delivery to algal cells by electroporation and sonication. Ultrasound Med Biol (2007) 0.89